Skip to main content

Compound-mediated Interferences in Homogeneous Proximity Assays- Recording

Homogeneous proximity assays are widely implemented in high-throughput screening (HTS) of small-molecule libraries for drug and chemical probe discovery. Representative technologies include AlphaScreen, Förster/fluorescence resonance energy transfer (FRET), time-resolved FRET (TR-FRET) and homogeneous time-resolved fluorescence (HTRF), bioluminescence resonance energy transfer (BRET), and scintillation proximity assays (SPA). While highly useful, these assay technologies are susceptible to a variety of technology-related compound-mediated interferences, most notably signal attenuation (e.g., quenching, inner-filter effects, light scattering), signal emission (e.g., auto-fluorescence), and disruption of affinity capture components such as affinity tags and antibodies. These assays are also susceptible to more generalized compound-mediated interferences such as nonspecific reactivity and aggregation.
This presentation describes:

  1. the basic principles of homogeneous proximity assays, 
  2. common sources of compound-mediated interference in homogeneous proximity assays, and
  3. counter-screens and other strategies to mitigate and identify compound-mediated assay interferences in homogeneous proximity assays. 
This information should be useful for prioritizing bioactive compounds in homogeneous proximity assays for drug and chemical probe discovery.

Trying to Access Videos? Click PURCHASE below. You will see the Member/Non-Member rate once you sign in.

FREE for SLAS Members
$20 for Non-members